Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China · Delayed Price · Currency is CNY 13.77
-0.65 (-4.51%)
Aug 21, 2026, 3:04 PM CST
SHE:300233 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 963.33 | 826.03 | 917.91 | 1,025 | 859.13 | 981.18 |
Trading Asset Securities | - | 70 | - | - | - | - |
Cash & Short-Term Investments | 963.33 | 896.03 | 917.91 | 1,025 | 859.13 | 981.18 |
Cash Growth | 27.73% | -2.38% | -10.42% | 19.27% | -12.44% | -8.75% |
Accounts Receivable | 665.93 | 691.8 | 696.8 | 794.56 | 803.39 | 684 |
Other Receivables | 3.89 | 3.23 | 6.29 | 7.81 | 4.62 | 5.08 |
Receivables | 669.82 | 695.03 | 703.09 | 802.37 | 808.01 | 689.08 |
Inventory | 486.59 | 464.61 | 598.86 | 501.28 | 579.22 | 391.32 |
Prepaid Expenses | - | - | - | 0.2 | 0.55 | 0.01 |
Other Current Assets | 49.59 | 30.16 | 38.42 | 40.77 | 61.24 | 77.68 |
Total Current Assets | 2,169 | 2,086 | 2,258 | 2,369 | 2,308 | 2,139 |
Property, Plant & Equipment | 2,043 | 2,148 | 2,310 | 2,468 | 2,469 | 2,093 |
Long-Term Investments | 180.71 | 181.84 | 183.28 | 147.52 | 141.22 | 143.31 |
Other Intangible Assets | 547.18 | 545.61 | 513.51 | 547.29 | 452.2 | 449.75 |
Long-Term Deferred Tax Assets | 37.41 | 47.6 | 63.94 | 69.77 | 51.96 | 30.71 |
Long-Term Deferred Charges | 102.34 | 147.98 | 252.96 | 310.89 | 369.59 | 329.72 |
Other Long-Term Assets | 28.52 | 33.93 | 23.5 | 3.51 | 34.42 | 89.77 |
Total Assets | 5,109 | 5,191 | 5,605 | 5,916 | 5,826 | 5,275 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 421.14 | 498.19 | 552.56 | 824 | 726.05 | 515.31 |
Accrued Expenses | 180.33 | 295.44 | 355.9 | 402.32 | 394.98 | 362.19 |
Short-Term Debt | 80.05 | 120.08 | 55.04 | 94 | 212.89 | 223 |
Current Portion of Long-Term Debt | 235.56 | 168.67 | 101.52 | 109.24 | 163.2 | 155.45 |
Current Portion of Leases | - | 1.77 | 0.13 | 0.72 | 1.11 | 2.37 |
Current Income Taxes Payable | 27.99 | 12.41 | 21.53 | 24.85 | 18.84 | 18.72 |
Current Unearned Revenue | 37.71 | 40.78 | 50.94 | 32.74 | 44.67 | 54.47 |
Other Current Liabilities | 153.94 | 84.76 | 93.35 | 112.47 | 139.2 | 84.94 |
Total Current Liabilities | 1,137 | 1,222 | 1,231 | 1,600 | 1,701 | 1,416 |
Long-Term Debt | 16.97 | 85.52 | 351.99 | 346.7 | 271.69 | 208.29 |
Long-Term Leases | 2.39 | 3.4 | 6.88 | 3.46 | 2.02 | 63.52 |
Long-Term Unearned Revenue | 40.85 | 45.24 | 53.88 | 61.6 | 66 | 54.81 |
Long-Term Deferred Tax Liabilities | 102.25 | 110.68 | 129.1 | 122.94 | 126.21 | 92.66 |
Other Long-Term Liabilities | 0.07 | - | - | - | - | - |
Total Liabilities | 1,299 | 1,467 | 1,773 | 2,135 | 2,167 | 1,836 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 383.87 | 383.87 | 383.87 | 383.87 | 387.41 | 387.41 |
Additional Paid-In Capital | 2,330 | - | - | 2,328 | 2,397 | 2,404 |
Retained Earnings | 1,025 | 943.38 | 1,051 | 967.95 | 850.41 | 653.34 |
Treasury Stock | -55.01 | -55.01 | -55.01 | - | -56.94 | -80.01 |
Comprehensive Income & Other | 61.84 | 2,391 | 2,387 | 34.62 | 29.33 | 29.44 |
Total Common Equity | 3,746 | 3,663 | 3,767 | 3,714 | 3,607 | 3,394 |
Minority Interest | 63.2 | 60.58 | 65.17 | 66.93 | 51.87 | 44.96 |
Shareholders' Equity | 3,810 | 3,724 | 3,832 | 3,781 | 3,659 | 3,439 |
Total Liabilities & Equity | 5,109 | 5,191 | 5,605 | 5,916 | 5,826 | 5,275 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 334.96 | 379.44 | 515.56 | 554.12 | 650.91 | 652.62 |
Net Cash (Debt) | 628.38 | 516.59 | 402.35 | 470.54 | 208.22 | 328.55 |
Net Cash Growth | 64.42% | 28.39% | -14.49% | 125.98% | -36.62% | -50.66% |
Net Cash Per Share | 1.75 | 1.40 | 1.06 | 1.21 | 0.54 | 0.85 |
Filing Date Shares Outstanding | 365.37 | 379.33 | 379.33 | 383.87 | 383.1 | 383.87 |
Total Common Shares Outstanding | 365.37 | 379.33 | 379.33 | 383.87 | 383.1 | 383.87 |
Working Capital | 1,033 | 863.75 | 1,027 | 768.95 | 607.21 | 722.83 |
Book Value Per Share | 10.25 | 9.66 | 9.93 | 9.68 | 9.42 | 8.84 |
Tangible Book Value | 3,199 | 3,118 | 3,253 | 3,167 | 3,155 | 2,945 |
Tangible Book Value Per Share | 8.76 | 8.22 | 8.58 | 8.25 | 8.24 | 7.67 |
Buildings | - | 1,539 | 1,424 | 1,406 | 1,356 | 1,021 |
Machinery | - | 2,441 | 2,414 | 2,289 | 2,152 | 1,671 |
Construction In Progress | - | 3.36 | 73.33 | 148.97 | 121.31 | 332.32 |